Catheter Precision
CARLSBAD, South Carolina, United States · Biotechnology, Health Care, Manufacturing
Catheter Precision, Inc. is a U.S.-based innovative medical device company focused on electrophysiology products, bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is committed to developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products.
Key facts
- Headquarters
- CARLSBAD, South Carolina, United States
- Employees
- 26
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Public (VTAK)
- Website
- catheterprecision.com
- Company page
Recent activity at Catheter Precision
- : SEC 8-K (3.02): On July 15, 2026, Catheter Precision, Inc. completed the closing of its issuance of 3,470 shares of Series C-3 Convertible Preferred Stock, each with a stated value of $1,000, totaling gross proceeds of approximately $3.47 million. This transaction was executed as part of a previously disclosed Securities Purchase Agreement from February 6, 2026, involving multiple investors. The issuance will provide the company with additional capital for its operations. The effective date of the transaction aligns with the filing date, confirming the event's recency and relevance.
- : Catheter Precision Inc. announces partnership with GSE Worldwide to enhance its heart failure technologies.
- : SEC 8-K (1.01): On June 7, 2026, Catheter Precision, Inc. entered into a Securities Purchase Agreement with Volato Group, Inc. and other investors. Under this agreement, Catheter Precision agreed to purchase 2,941,176 shares of Volato's common stock at a price of $0.34 per share, totaling an aggregate purchase price of $1,000,000. The Private Placement is significant as it involves a notable investment in Volato, although there is no assurance that Catheter Precision will realize the current market value of the securities in future sales. The closing date of the transaction is expected to occur soon after, reflecting active capital engagement in the market.
- : Catheter Precision, Inc. Secures $1 Million Investment
- : SEC 8-K (5.07): On April 15, 2026, Catheter Precision, Inc. held a Special Meeting of stockholders where approximately 49.5% of the outstanding shares were represented. The stockholders voted on six proposals, including the approval of the issuance of shares of common stock under a specific plan. The meeting was attended either in person or by proxy by 1,165,698 shares out of the 2,357,127 outstanding shares as of March 9, 2026. A detailed description of the proposals can be found in the definitive proxy statement filed with the SEC on March 23, 2026.
- : Catheter Precision acquires Fly Flyte for $11.55M
- : Catheter Precision, Inc. secures up to $36.5M in financing to accelerate growth. This strategic institutional capital aims to strengthen the balance sheet and enhance shareholder value.
- : SEC 8-K (5.02): On October 10, 2025, Catheter Precision, Inc. held a Special Meeting of stockholders to vote on three proposals, including an amendment to the Amended and Restated Certificate of Incorporation. Out of 1,487,266 shares of common stock outstanding as of the record date, September 10, 2025, 641,616 shares were represented at the meeting, accounting for approximately 43.1% of the shares entitled to vote. This vote reflects important decisions that could affect the company’s governance structure and future business operations, as it involved changes to fundamental corporate documents. Details of the proposals and the outcomes were provided in the definitive proxy statement filed with the SEC on September 15, 2025.
- : Catheter Precision, Inc. raised $1.5 million in a private equity financing led by institutional investors to expand its cardiac product lines.
- : Catheter Precision Inc. Engages PCG Advisory to Enhance Investor Outreach and Communication Efforts
Catheter Precision funding history
| Date | Round | Amount |
|---|---|---|
| Jun 2026 | Post-IPO Equity | $1.0M |
| Feb 2026 | Funding Round | $36.5M |
| May 2025 | Private Equity | $1.5M |
| Apr 2023 | Venture | $8.0M |
| Aug 2022 | Venture | $6.2M |
Leadership
- Joan Stafslien, Director
- Susanne Meline, Director
- Richard Mejia, Director
- Martin Colombatto, Director
- Will McGuire, Executive Officer, Director
- Maurice Buchbinder, Director
- Martin Burstein, Director
- Martin Colombatto, Director
- Richard Heymann, Director
- Melissa Burstein, Executive Officer, Director
- Dean Irwin, Executive Officer, Director
- Martin Colombatto, Director
Verified email and direct lines for Catheter Precision’s decision-makers are on Fundz. See plans
Catheter Precision in the news
Companies similar to Catheter Precision
- Ronovo Surgical · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- USM Healthcare · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- Tenon Medical · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- Thor Medical ASA · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- Endo Tools Therapeutics · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
About Catheter Precision: questions and answers
What does Catheter Precision do?
Catheter Precision, Inc. is a U.S.-based innovative medical device company focused on electrophysiology products, bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is committed to developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products.
Where is Catheter Precision headquartered?
Catheter Precision is headquartered in CARLSBAD, South Carolina, United States.
How many employees does Catheter Precision have?
Catheter Precision has about 26 employees.
Has Catheter Precision raised funding?
Yes. Fundz has recorded 5 funding events for Catheter Precision. The most recent, Post-IPO Equity of $1.0M, was in Jun 2026.
What is the latest news on Catheter Precision?
On Jul 14, 2026, SEC 8-K (3.02): On July 15, 2026, Catheter Precision, Inc. completed the closing of its issuance of 3,470 shares of Series C-3 Convertible Preferred Stock, each with a stated value of $1,000, totaling gross proceeds of approximately $3.47 million. This transaction was executed as part of a previousl
Is Catheter Precision a public company?
Yes. Catheter Precision is publicly traded under the ticker VTAK.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy